Premium
Use of Tissue Plasminogen Activator in a Stroke After Radiofrequency Ablation of a Left‐Sided Accessory Pathway
Author(s) -
CAN BRYAN C.,
KERTESZ NAOMI J.,
FRIEDMAN RICHARD A.,
FENRICH ARNOLD L.
Publication year - 2001
Publication title -
journal of cardiovascular electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.193
H-Index - 138
eISSN - 1540-8167
pISSN - 1045-3873
DOI - 10.1046/j.1540-8167.2001.00723.x
Subject(s) - medicine , accessory pathway , stroke (engine) , tissue plasminogen activator , ablation , recombinant tissue plasminogen activator , radiofrequency ablation , cardiology , thrombus , thromboembolic stroke , catheter ablation , atrial fibrillation , surgery , ischemic stroke , modified rankin scale , ischemia , engineering , mechanical engineering
Use of tPA in a Stroke After RF Ablation. We describe the case of a 12‐year‐old girl who had a thromboembolic stroke after radiofrequency ablation of a left posterior accessory pathway involving a transseptal procedure. Symptoms of a stroke occurred 7 hours 15 minutes after completion of the procedure. Tissue plasminogen activator (tPA) was given 2 hours 30 minutes after the onset of symptoms, with complete resolution of her neurologic symptoms. No adverse effects from the tPA were seen. Because of the late onset of symptoms in this case, overnight in‐hospital observation is warranted for patients who undergo radiofrequency ablation of a left‐sided accessory pathway or an accessory pathway in a patient with the ability to shunt right to left. In this case, tPA was an effective and safe drug to use following a cerebral thromboembolic event occurring after a cardiac catheterization procedure.